248 related articles for article (PubMed ID: 21889481)
1. RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2.
Jones K; Jin B; Iakova P; Huichalaf C; Sarkar P; Schneider-Gold C; Schoser B; Meola G; Shyu AB; Timchenko N; Timchenko L
Am J Pathol; 2011 Nov; 179(5):2475-89. PubMed ID: 21889481
[TBL] [Abstract][Full Text] [Related]
2. (CCUG)
Yenigun VB; Sirito M; Amcheslavky A; Czernuszewicz T; Colonques-Bellmunt J; García-Alcover I; Wojciechowska M; Bolduc C; Chen Z; López Castel A; Krahe R; Bergmann A
Dis Model Mech; 2017 Aug; 10(8):993-1003. PubMed ID: 28623239
[TBL] [Abstract][Full Text] [Related]
3. CCUG repeats reduce the rate of global protein synthesis in myotonic dystrophy type 2.
Schneider-Gold C; Timchenko LT
Rev Neurosci; 2010; 21(1):19-28. PubMed ID: 20458885
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of protein homeostasis in myotonic dystrophies.
Meola G; Jones K; Wei C; Timchenko LT
Histol Histopathol; 2013 Sep; 28(9):1089-98. PubMed ID: 23536431
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic mechanisms of myotonic dystrophy.
Lee JE; Cooper TA
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1281-6. PubMed ID: 19909263
[TBL] [Abstract][Full Text] [Related]
6. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.
Sellier C; Cerro-Herreros E; Blatter M; Freyermuth F; Gaucherot A; Ruffenach F; Sarkar P; Puymirat J; Udd B; Day JW; Meola G; Bassez G; Fujimura H; Takahashi MP; Schoser B; Furling D; Artero R; Allain FHT; Llamusi B; Charlet-Berguerand N
Nat Commun; 2018 May; 9(1):2009. PubMed ID: 29789616
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
Timchenko L
Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
[TBL] [Abstract][Full Text] [Related]
8. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1.
Timchenko NA; Cai ZJ; Welm AL; Reddy S; Ashizawa T; Timchenko LT
J Biol Chem; 2001 Mar; 276(11):7820-6. PubMed ID: 11124939
[TBL] [Abstract][Full Text] [Related]
9. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA
Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324
[TBL] [Abstract][Full Text] [Related]
10. Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.
Wang M; Weng WC; Stock L; Lindquist D; Martinez A; Gourdon G; Timchenko N; Snape M; Timchenko L
Mol Cell Biol; 2019 Nov; 39(21):. PubMed ID: 31383751
[TBL] [Abstract][Full Text] [Related]
11. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
12. Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1.
Wei C; Stock L; Valanejad L; Zalewski ZA; Karns R; Puymirat J; Nelson D; Witte D; Woodgett J; Timchenko NA; Timchenko L
FASEB J; 2018 Apr; 32(4):2073-2085. PubMed ID: 29203592
[TBL] [Abstract][Full Text] [Related]
13. Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats.
Kino Y; Mori D; Oma Y; Takeshita Y; Sasagawa N; Ishiura S
Hum Mol Genet; 2004 Mar; 13(5):495-507. PubMed ID: 14722159
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
15. Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.
Wojciechowska M; Taylor K; Sobczak K; Napierala M; Krzyzosiak WJ
RNA Biol; 2014; 11(6):742-54. PubMed ID: 24824895
[TBL] [Abstract][Full Text] [Related]
16. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
[TBL] [Abstract][Full Text] [Related]
17. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.
Koshelev M; Sarma S; Price RE; Wehrens XH; Cooper TA
Hum Mol Genet; 2010 Mar; 19(6):1066-75. PubMed ID: 20051426
[TBL] [Abstract][Full Text] [Related]
18. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
[TBL] [Abstract][Full Text] [Related]
19. Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients.
Salisbury E; Schoser B; Schneider-Gold C; Wang GL; Huichalaf C; Jin B; Sirito M; Sarkar P; Krahe R; Timchenko NA; Timchenko LT
Am J Pathol; 2009 Aug; 175(2):748-62. PubMed ID: 19590039
[TBL] [Abstract][Full Text] [Related]
20. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression.
Margolis JM; Schoser BG; Moseley ML; Day JW; Ranum LP
Hum Mol Genet; 2006 Jun; 15(11):1808-15. PubMed ID: 16624843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
